切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Synthases/Synthetases - Topoisomerases - CSF1R - Inward Rectifier Potassium (Kir) Channels

27件产品中的 11-20

页面
每页
清除全部
  1. Irinotecan HCl Trihydrate
    B2293 Irinotecan HCl Trihydrate
    中文名: 盐酸依立替康三水合物
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.1 mg/mL
      ≥2.5 mg/mL
  2. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  3. Beta-Lapachone
    B2290 Beta-Lapachone
    中文名: β-拉帕醌
    Target: Topoisomerases
    Summary: 选择性DNA拓扑异构酶I抑制剂
      ≥10.85 mg/mL
      insoluble in H2O
  4. Clinafloxacin CI96 AM1091
    A8400 Clinafloxacin CI96 AM1091
    中文名: 克林沙星
    Target: Topoisomerases
    Summary: 拓扑异构酶抑制剂
      ≥3.66 mg/mL
      insoluble in H2O
  5. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  6. Ofloxacin
    A5511 Ofloxacin
    中文名: 氧氟沙星
    Target: Topoisomerases|DNA gyrase
    Summary: 氟喹诺酮类抗生素
      ≥12.03 mg/mL
      insoluble in H2O
  7. Oligomycin A
    A5588 Oligomycin A
     1 Citation
    中文名: 寡霉素A
    Target: Synthases/Synthetases
    Summary: 线粒体ATP合成酶抑制剂
      ≥9.89 mg/mL
      insoluble in H2O
  8. Dexrazoxane HCl (ICRF-187, ADR-529)
    A1602 Dexrazoxane HCl (ICRF-187, ADR-529)
    中文名: 右雷佐生盐酸盐
    Target: Topoisomerases
    Summary: 拓扑异构酶II抑制剂,细胞内离子螯合剂,心脏保护剂
      ≥15.24 mg/mL
      ≥16 mg/mL
  9. Epirubicin HCl
    A2451 Epirubicin HCl
    中文名: 盐酸表阿霉素
    Target: Topoisomerases
    Summary: 抗生素类抗肿瘤药物
      ≥29.00 mg/mL
      ≥40.33 mg/mL
  10. Etoposide
    A1971 Etoposide
     4 Citation
    中文名: 依托泊苷
    Target: Topoisomerases
    Summary: 拓扑异构酶II(Topo II)抑制剂
      ≥29.45 mg/mL
      insoluble in H2O

27件产品中的 11-20

页面
每页